The anti-APP antibody 2B3 specifically binds amyloid precursor protein from which the β-amyloid is cleaved. By binding the APP and therefore reducing the accumulation or the release of β-amyloid, the antibody can be used in the treatment of conditions related with elevated levels of β-amyloid, such as Alzheimer's Disease.
Figure 1 Representative Western blot of MOG-G-UVW lysate (50μg) detected with either 2B3 or 2B12 at 2μg/ml on a 10% gel.
Both antibodies detected full length APP at 103KDa (±2.5 KDa) and a smaller protein at 56KDa (±0.6 KDa), which was most likely a thrombin cleavage fragment of APP.
Thomas, R. S., Liddell, J. E., & Kidd, E. J. (2011). Anti‐amyloid precursor protein immunoglobulins inhibit amyloid‐β production by steric hindrance. The FEBS journal, 278(1), 167-178.
Figure 2 Differential 2B3 and 2B12 recognition of sAPPα and sAPPβ as determined by indirect ELISA.
Data are expressed as a mean (± SEM) % of the standard antibody (6E10) at 0.1μg/ml. 2B12 recognised sAPPα and sAPPβ equally well, however, significantly more 2B3 bound to sAPPα than to sAPPβ.
Thomas, R. S., Liddell, J. E., & Kidd, E. J. (2011). Anti‐amyloid precursor protein immunoglobulins inhibit amyloid‐β production by steric hindrance. The FEBS journal, 278(1), 167-178.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-225 | Anti-Human Abeta Recombinant Antibody (Bapineuzumab) | WB, FuncS, IF, Neut, ELISA, FC, IP | IgG1 |
TAB-228 | Anti-Human Abeta Recombinant Antibody (Solanezumab) | WB, FuncS, IF, Neut, ELISA, FC, IP | IgG1 - kappa |
TAB-253CQ-S(P) | Human Anti-APP Recombinant Antibody; scFv Fragment (TAB-253CQ-S(P)) | ELISA | Humanized scFv |
TAB-253CQ-F(E) | Human Anti-APP Recombinant Antibody; Fab Fragment (TAB-253CQ-F(E)) | ELISA | Humanized Fab |
TAB-0828CLV | Human Anti-APP Recombinant Antibody (TAB-0828CLV) | ELISA | Humanized antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-010 | Mouse Anti-APP Recombinant Antibody (clone 12A11) | WB, IF, FuncS | Mouse IgG2a, κ |
PABL-011 | Mouse Anti-APP Recombinant Antibody (clone 3D6) | WB, ELISA, FuncS | Mouse IgG1 |
PABL-012 | Human Anti-APP Recombinant Antibody (clone 9TL) | WB, FuncS | Human IgG2, κ |
PABL-013 | Mouse Anti-APP Recombinant Antibody (clone C705) | WB, ELISA, FuncS | Mouse IgG |
PABW-009 | Mouse Anti-APP Recombinant Antibody (clone PFA1) | ELISA | Mouse IgG2a |
CAT | Product Name | Application | Type |
---|---|---|---|
PFBW-009 | Mouse Anti-APP Recombinant Antibody (clone PFA1); Fab Fragment | ELISA | Mouse IgG2a |
PFBC-010 | Mouse Anti-APP Recombinant Antibody (clone PFA2); Fab Fragment | ELISA | Mouse IgG2a |
HPAB-0104-YJ-F(E) | Mouse Anti-APP Recombinant Antibody (clone 5E3); Fab Fragment | ELISA, WB | Mouse Fab |
HPAB-0105-YJ-F(E) | Human Anti-APP Recombinant Antibody (clone hu5E3); Fab Fragment | ELISA, WB | Humanized Fab |
HPAB-0255-YJ-F(E) | Human Anti-APP Recombinant Antibody (clone CBA45YJ); Fab Fragment | ELISA, WB, Inhib, FuncS | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-0019CL-VHH | Camelid Anti-APP Recombinant Antibody (TAB-0019CL-VHH) | IHC, WB | Camelid VHH |
TAB-0020CL-VHH | Anti-Human APP VHH Single Domain Antibody (TAB-0020CL-VHH) | ELISA, IHC | Single domain antibody |
TAB-0021CL-VHH | Anti-Human APP VHH Single Domain Antibody (TAB-0021CL-VHH) | ELISA, In vivo, FuncS | Single domain antibody |
TAB-0022CL-VHH | Anti-Human APP VHH Single Domain Antibody (TAB-0022CL-VHH) | ELISA, In vivo, FuncS | Single domain antibody |
TAB-0023CL-VHH | Anti-Human APP VHH Single Domain Antibody (TAB-0023CL-VHH) | ELISA, In vivo, FuncS | Single domain antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-254CQ | Human Anti-APP Recombinant Antibody (TAB-254CQ) | ELISA | Chimeric (mouse/human) IgG1 |
TAB-254CQ-F(E) | Human Anti-APP Recombinant Antibody; Fab Fragment (TAB-254CQ-F(E)) | ELISA | Chimeric (mouse/human) Fab |
TAB-0789CLV | Human Anti-APP Recombinant Antibody (TAB-0789CLV) | IP | Chimeric (mouse/human) IgG |
TAB-0802CLV | Human Anti-APP Recombinant Antibody (TAB-0802CLV) | ELISA | Chimeric (mouse/human) IgG1, κ |
TAB-0789CLV-F(E) | Human Anti-APP Recombinant Antibody; Fab Fragment (TAB-0789CLV-F(E)) | ELISA | Chimeric (mouse/human) Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-0805CLV | Anti-Human APP Recombinant Antibody (82 E 1) | WB | |
TAB-0808CLV | Mouse Anti-APP Recombinant Antibody (TAB-0808CLV) | ELISA | Mouse IgG2a |
TAB-0809CLV | Anti-Human APP Recombinant Antibody (3D6) | IF | |
TAB-0782CLV-F(E) | Mouse Anti-APP Recombinant Antibody; Fab Fragment (TAB-0782CLV-F(E)) | ELISA | Mouse Fab |
TAB-0792CLV-S(P) | Mouse Anti-APP Recombinant Antibody; scFv Fragment (TAB-0792CLV-S(P)) | ELISA | Mouse scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-0783CLV-F(E) | Human Anti-APP Recombinant Antibody; Fab Fragment (TAB-0783CLV-F(E)) | ELISA, FuncS | Human Fab |
TAB-0784CLV-F(E) | Human Anti-APP Recombinant Antibody; Fab Fragment (TAB-0784CLV-F(E)) | ELISA | Human Fab |
TAB-0785CLV-F(E) | Human Anti-APP Recombinant Antibody; Fab Fragment (TAB-0785CLV-F(E)) | ELISA | Human Fab |
TAB-0786CLV-F(E) | Human Anti-APP Recombinant Antibody; Fab Fragment (TAB-0786CLV-F(E)) | ELISA | Human Fab |
TAB-0815CLV-S(P) | Human Anti-APP Recombinant Antibody; scFv Fragment (TAB-0815CLV-S(P)) | ELISA | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
BRD-0685MZ | Chicken Anti-APP Polyclonal IgY | IHC | Chicken antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
PABX-014 | Hi-Affi™ Rabbit Anti-APP Recombinant Antibody (clone M204) | WB, ELISA, FuncS | Rabbit IgG |
PABX-014-F (E) | Hi-Affi™ Rabbit Anti-APP Recombinant Antibody (clone M204); Fab Fragment | WB, ELISA, FuncS | Rabbit Fab |
MOR-0220 | Hi-Affi™ Rabbit Anti-APP Recombinant Antibody (clone DS220AB) | ELISA, WB | Rabbit IgG |
MOR-4539 | Hi-Affi™ Rabbit Anti-APP Recombinant Antibody (clone TH47DS) | IHC-P, ELISA | Rabbit IgG |
MOR-0082-FY | Rabbit Anti-APP Recombinant Antibody (clone AFY0053) | ICC, IHC-P, WB | Rabbit IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
EPAF-0566CQ | Mouse Anti-APP Recombinant Antibody (clone 6E10) | ELISA | Mouse IgG |
EPAF-0567CQ | Mouse Anti-APP Recombinant Antibody (clone 4G8) | ELISA, IHC | Mouse IgG2b |
EPAF-0568CQ | Human Anti-APP Recombinant Antibody (clone HyL5) | ELISA, Inhib | Human IgM |
EPAF-0569CQ | Mouse Anti-APP Recombinant Antibody (clone AB1-42) | IHC | Mouse IgG |
EPAF-0570CQ | Human Anti-APP Recombinant Antibody (clone L11.3) | IHC, ELISA, Inhib | Human IgM |
CAT | Product Name | Application | Type |
---|---|---|---|
NS-001CN | Human Anti-APP Recombinant Antibody (clone AS) | WB | Human IgG |
NS-007CN | Mouse Anti-APP Recombinant Antibody (NS-007CN) | ELISA, FuncS | Mouse IgG1 |
NS-001CN-F(E) | Human Anti-APP Recombinant Antibody (clone AS); Fab Fragment | WB | Human Fab |
NS-007CN-F(E) | Mouse Anti-APP Recombinant Antibody; Fab Fragment (NS-007CN-F(E)) | ELISA | Mouse Fab |
NS-001CN-S(P) | Human Anti-APP Recombinant Antibody (clone AS); scFv Fragment | WB | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
PSBC-394 | Mouse Anti-APP Recombinant Antibody (clone c#6); scFv Fragment | ELISA, WB, FuncS | Mouse scFv |
PSBC-395 | Mouse Anti-APP Recombinant Antibody (clone c#24); scFv Fragment | ELISA, WB, FuncS | Mouse scFv |
PSBC-527 | Mouse Anti-APP Recombinant Antibody (clone c#17); scFv Fragment | ELISA, WB, FuncS | Mouse scFv |
HPAB-S0005-YC-S(P) | Human Anti-APP Recombinant Antibody (clone ch3D6); scFv Fragment | ELISA, FuncS | Human scFv |
HPAB-1828-FY-F(E) | Mouse Anti-APP Recombinant Antibody (clone 2324); scFv Fragment | ELISA | Mouse scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
AFC-TAB-225 | Afuco™ Anti-APP ADCC Recombinant Antibody (Bapineuzumab), ADCC Enhanced | FuncS, IF, Neut, ELISA, FC | ADCC enhanced antibody |
AFC-TAB-228 | Afuco™ Anti-APP ADCC Recombinant Antibody (Solanezumab), ADCC Enhanced | FuncS, IF, Neut, ELISA, FC | ADCC enhanced antibody |
AFC-TAB-229 | Afuco™ Anti-APP ADCC Recombinant Antibody (Gantenerumab), ADCC Enhanced | FuncS, IF, Neut, ELISA, FC, IP | ADCC enhanced antibody |
AFC-TAB-227 | Afuco™ Anti-APP ADCC Recombinant Antibody (Ponezumab), ADCC Enhanced | ELISA, IP, FC, FuncS, Neut | ADCC enhanced antibody |
AFC-TAB-226 | Afuco™ Anti-APP ADCC Recombinant Antibody (Crenezumab), ADCC Enhanced | IF, IP, Neut, FuncS, ELISA | ADCC enhanced antibody |
There are currently no Customer reviews or questions for TAB-0847CLV. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.